AN2 Therapeutics, Inc., (ANTX): Price and Financial Metrics

AN2 Therapeutics, Inc., (ANTX): $1.08

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ANTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#240 of 328

in industry

ANTX Price/Volume Stats

Current price $1.08 52-week high $22.22
Prev. close $1.08 52-week low $0.87
Day low $1.08 Volume 132,400
Day high $1.09 Avg. volume 380,853
50-day MA $1.07 Dividend yield N/A
200-day MA $3.54 Market Cap 32.23M

ANTX Stock Price Chart Interactive Chart >


AN2 Therapeutics, Inc., (ANTX) Company Bio


AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.


ANTX Latest News Stream


Event/Time News Detail
Loading, please wait...

ANTX Latest Social Stream


Loading social stream, please wait...

View Full ANTX Social Stream

ANTX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!